Disclosure of conflicts of interest/competing interests

Status: PUBLIC REVIEW 

Notice: These recommendations are under public review from 6 December 2017 through 6 January 2018. Comments should be made directly on the working Google doc.

 Context

<author-notes>, <contrib-group>, <contrib>, <fn>

Objective of these recommendations

To enable machines to identify Conflicts of Interest (COI)/competing interests statements as they pertain to the contributor(s) of a particular article.

Description

This recommendation contains best practices for tagging COI statements in article-level metadata.

N.B. The purpose of this recommendation is to provide for the interoperability of COI statements; however, the method of tagging of these statements may vary depending on a journal’s policy on COI statements and the required level of granularity. Therefore, the following recommendations allow for varying levels of specificity in how this information is captured.

Additional reading

Recommendations

  1. Statement placement. Put the COI in a <fn> element within the <author-notes> section of the <front>
  2. <fn> Use @fn-type=”COI-statement” to identify the footnote as a COI statement
  3. Linking COI statements to contributors. An article can contain one or more COI statements and the statement(s) can be linked to individual contributors, though this linking is not required. In cases where these linkages to exist in the XML, use an <xref> element with an @ref-type=”author-notes” and assign it an @rid as needed

Examples

Example 1: A single COI statement that applies that to all contributors. Not explicitly linked to individual contributors in the XML.

 <contrib-group>
    <contrib contrib-type="author">
       <string-name>
          <given-names>Rafer</given-names>
          <surname>Alston</surname>
       </string-name>
   </contrib>
   <contrib contrib-type="author">
      <string-name>
         <given-names>Antonio</given-names>
         <surname>Davis</surname>
         </string-name>
   </contrib>
 <author-notes>
 <fn fn-type="COI-statement">
 <p>Competing Interests: The authors have declared that no competing interests exist.</p>
 </fn>
 </author-notes>
</contrib-group>

Example 2: A single COI statement that applies that to all contributors. The statements are explicitly linked to individual contributors in the XML using <id> and <xref> elements.

<contrib-group>
 <contrib contrib-type="author">
 <string-name>
 <given-names>Jerome</given-names>
 <surname>Williams</surname>
 </string-name>
 <xref ref-type="author-notes" rid="con1"/>
 </contrib>
 <contrib contrib-type="author">
 <string-name>
 <given-names>Morris</given-names>
 <surname>Peterson</surname>
 <xref ref-type="author-notes" rid="con1"/>
 </string-name>
 </contrib>
 </contrib-group>
 <author-notes>
 <fn fn-type="COI-statement" id="con1">
 <p>Competing Interests: The authors have declared that no competing interests exist.</p>
 </fn>
 </author-notes>

Example 3: Multiple COI statements, each linked to individual contributors in the XML.

 <contrib contrib-type="author">
 <string-name>
 <given-names>Alvin</given-names>
 <surname>Williams</surname>
 </string-name>
 <xref ref-type="author-notes" rid="con1"/>
 </contrib>
 <contrib contrib-type="author">
 <string-name>
 <given-names>Voshon</given-names>
 <surname>Lenard</surname>
 <xref ref-type="author-notes" rid="con2"/>
 </string-name>
 </contrib>
 </contrib-group>
 
 <author-notes>
 <fn fn-type="COI-statement" id="con1">
 <p>Conflicts of Interest Statement: Alvin Williams is a member of the Health 
 Technology Assessment (HTA) Primary Care, Community and Preventive 
 Interventions (PCCPI) Panel. In the last 3 years he has
 received speaker&#x02019;s honoraria for speaking at sponsored meetings or
 satellite symposia at conferences from the following companies, marketing
 respiratory and allergy products: Aerocrine, GlaxoSmithKline (GSK) and Novartis
 International AG. He has received honoraria for attending advisory panels with
 Aerocrine, AstraZeneca, Boehringer Ingelheim, GSK and Novartis. He has received
 sponsorship to attend international scientific meetings from GSK and AstraZeneca
 and has received funding for research projects from GSK. He is a member of the
 British Thoracic Society (BTS)/Scottish Intercollegiate Guidelines Network
 (SIGN) Asthma Guideline Group and the National Institute for Health and Care
 Excellence (NICE) Asthma Guideline Group.</p>
 </fn>
 <fn fn-type="COI-statement" id="con2">
 <p>Conflicts of Interest Statement: Voshon Lenard is Editor-in-Chief of the
 <italic>Programme Grants for Applied Research</italic> journal and is a
 member of the National Institute for Health Research (NIHR) Journals Library
 Board.</p>
 </fn>
 </author-notes>
<title>Data Availability</title>
<p>The data analysis file and all annotator data files are available in the Figshare repository, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.1285515">https://doi.org/10.6084/m9.figshare.1285515</ext-link> [<xref ref-type="bibr" rid="pone.0167292.ref032">32</xref>]. The measured and simulated Euler angles, and the simulation codes are available from the Dryad database, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.cv323">https://doi.org/10.5061/dryad.cv323</ext-link> [<xref ref-type="bibr" rid="pone.0167292.ref033">33</xref>]. Microarray data are deposited in the Gene Expression Omnibus under accession number <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70542>GSE70542</ext-link> [<xref ref-type="bibr" rid="pone.0167292.ref034">34</xref>].</p>
</data-availability>
<ref-list>
<title>References</title>
[Insert references here]
</ref-list>
</back>